What amount sold does Tianzheng Biotechnology Inc report in Form D filings?

The latest linked filings report $0 sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Tianzheng Biotechnology Inc's most recent SEC filing?

Tianzheng Biotechnology Inc's most recent Form D filing was on 2026-07-13.

What type of securities does Tianzheng Biotechnology Inc offer?

Tianzheng Biotechnology Inc's SEC Form D filings indicate equity offerings.

Tianzheng Biotechnology Inc

CIK: 0002145260·Other Technology·DENVER, CO·Corporation·Founded 2026

Reported Sold

Total Filings

Identified Offerings

Last Filed

Jul 13, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Technology industry

SEC EDGAR

Offering filing timeline

Jul 13, 2026Form D — New notice

Reported sold: $0 · Target: $5,000,000

Section 4(a)(2)·0 investors

Fundraising Profile

Exemptions

Section 4(a)(2)

Investors in latest filing

Revenue Range

$5,000,001 - $25,000,000

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Filing History

Date	Type	Offering target	Reported sold	Investors
Jul 13, 2026	New	$5,000,000	$0	0

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

LXRE Inc.

Other Technology

Offering target: $4,000,000

Filed Oct 22, 2026